Michael Meyring
Impact in
- Hepatology top 10%
- Liver physiology and pathology
- Spectroscopy top 5%
- Analytical Chemistry and Chromatography
- Mass Spectrometry Techniques and Applications
Papers in
-
- Liver physiology and pathology 7
- Hepatocellular Carcinoma Treatment and Prognosis 2
- Oncology 5
- Cancer Treatment and Pharmacology 2
- Co-authors
- Gottfried Blaschke (6 shared papers)Bezhan Chankvetadze (4 shared papers)Dieter Dorsch (6 shared papers)Manja Friese‐Hamim (6 shared papers)Oliver Schadt (6 shared papers)Andree Blaukat (6 shared papers)Friedhelm Bladt (7 shared papers)Frank Stieber (6 shared papers)
- Journals
- Cancer Research (4 papers)Electrophoresis (2 papers)Journal of Pharmaceutical Sciences (1 paper)Clinical Cancer Research (1 paper)Investigational New Drugs (1 paper)
- Partner nations
- GermanyItalySwitzerland
In The Last Decade
Michael Meyring
17 papers receiving 444 citations
Peers
Comparison fields: 5 of 71
- Hepatology 96
- Spectroscopy 153
- Oncology 92
- Biomedical Engineering 131
- Hematology 33
Countries citing papers authored by Michael Meyring
This map shows the geographic impact of Michael Meyring's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael Meyring with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael Meyring more than expected).
Fields of papers citing papers by Michael Meyring
This network shows the impact of papers produced by Michael Meyring. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael Meyring. The network helps show where Michael Meyring may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael Meyring, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2013 | 114 | |
| 2 | 2000 | 80 | |
| 3 | 2015 | 68 | |
| 4 | 2002 | 41 | |
| 5 | 1999 | 31 | |
| 6 | 1999 | 29 | |
| 7 | 2000 | 24 | |
| 8 | 2020 | 17 | |
| 9 | 2002 | 13 | |
| 10 | 2012 | 11 | |
| 11 | 2013 | 9 | |
| 12 | 2014 | 8 | |
| 13 | 2010 | 4 | |
| 14 | 2015 | 2 | |
| 15 | 2011 | 2 | |
| 16 | 2010 | 1 | |
| 17 | 2010 | 1 |
About Michael Meyring
Michael Meyring is a scholar working on Hepatology, Oncology, Biomedical Engineering, Pathology and Forensic Medicine and Pharmacology, having authored 17 papers that have together received 455 indexed citations. Recurring topics across this work include Liver physiology and pathology (7 papers), Microfluidic and Capillary Electrophoresis Applications (4 papers), Analytical Chemistry and Chromatography (3 papers), Pharmacogenetics and Drug Metabolism (3 papers), Cancer Mechanisms and Therapy (3 papers), Innovative Microfluidic and Catalytic Techniques Innovation (3 papers), Cancer Treatment and Pharmacology (2 papers) and Hepatocellular Carcinoma Treatment and Prognosis (2 papers). The work is most often cited by research in Hepatology (96 citations), Spectroscopy (153 citations), Oncology (92 citations), Biomedical Engineering (131 citations) and Hematology (33 citations). Michael Meyring has collaborated with scholars based in Germany, Italy and Switzerland. Frequent co-authors include Gottfried Blaschke, Bezhan Chankvetadze, Dieter Dorsch, Manja Friese‐Hamim, Oliver Schadt, Andree Blaukat, Friedhelm Bladt, Frank Stieber, Ulrich Grädler and Ulrich Pehl. Their work appears in journals such as Cancer Research, Electrophoresis, Journal of Pharmaceutical Sciences, Clinical Cancer Research and Investigational New Drugs.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.